The chief of Serum Institute of India Adar Poonawalla announced that the company is looking forward to launch a second coronavirus vaccine, which if approved, could be India's third COVID-19 vaccine. Covishield has been developed by SII in partnership with the Oxford University and British-Swedish firm AstraZeneca.
from Zee News :India National https://ift.tt/3cnZl8l
from Zee News :India National https://ift.tt/3cnZl8l
Comments
Post a Comment